While the proposed rescheduling of marijuana to a Schedule III drug remains up in the air, a number of other events are taking place that
On May 16, 2024, The Drug Enforcement Administration, Department of Justice published a proposal to transfer marijuana from Schedule I to Schedule III of the
Despite the six months that have passed since the Department of Health and Human Services (HHS) recommendation to the Drug Enforcement Agency (DEA) to reclassify
With four states adding or updating marijuana legislation in 2023, only 10 states remain as outliers, allowing no legal medical or adult-use marijuana. Coming on
What cannabis policies are U.S. federal agencies prioritizing? What do they see as the potential impacts of its legalization and use? Although many states have
The disconnect between the state and federal governments on cannabis legislation is showing itself in the medical community as well. In late September, the American
As you likely have seen by now, a federal recommendation has been made to reclassify marijuana as a Schedule III drug from its current status
The lack of clear cannabis regulation/acceptance at the federal level has again reared its ugly head causing further complications for both consumers and dispensaries –
State investigators have uncovered numerous instances of marijuana product adulteration by businesses attempting to manipulate contaminant testing. (Colorado MED) One of the fundamental incentives for
